MEG3 and neoplasm: Similarly, EVs derived from adipose-tissue-derived MSC (AT-MSC) loaded with the long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) inhibit tumor cell proliferation and tumor growth via a mechanism dependent on PTEN activation and the inhibition of the β-catenin pathway [127,128].